Inspiratory muscle endurance is similarly reduced in the early and late stages of chronic Chagas heart disease.
Chagas disease
Chagas heart disease
heart failure
inspiratory muscle endurance
inspiratory muscle strength
Journal
Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576
Informations de publication
Date de publication:
19 Mar 2024
19 Mar 2024
Historique:
medline:
20
3
2024
pubmed:
20
3
2024
entrez:
19
3
2024
Statut:
aheadofprint
Résumé
Inspiratory muscle strength (IMS) appears to be reduced in subjects with chronic Chagas heart disease (CHD), especially in the presence of heart failure (HF). However, only one study about IMS and inspiratory muscle endurance (IME) in those with CHD without heart failure is available. This study aimed to compare IMS and IME in subjects with CHD in the presence and absence of HF. This is a cross-sectional study in which 30 CHD adult patients were divided into CHD-CC group (initial phase of CHD, without HF; n = 15) and CHD-HF group (advanced phase of CHD, with HF; n = 15). We assessed IMS by maximum inspiratory pressure (MIP) and IME by incremental (Pthmax) and constant load (TLim) tests. Reduced IMS and IME were considered by predicted MIP values <70% and Pthmax/MIP <75%, respectively. Inspiratory muscle weakness (IMW) was more frequent in CHD-HF than in CHD-CC (46.7% vs. 13.3%; p = 0.05), and both groups had high frequencies of reduced IME (93.3% CHD-CC vs. 100.0% CHD-HF; p = 0.95). Age-adjusted logistic regression analysis using HF as a dependent variable showed that HF was associated with an increased chance of IMW compared with the CHD-CC group (OR = 7.47; p = 0.03; 95% CI 1.20-46.19). This study suggests that, in patients with CHD, HF is associated with IMW, and that reduction of IME is already present in the initial phase, similar to the advanced phase with HF.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : The Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation
ID : ARC/2019
Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
World Health Organization. Chagas disease (American trypanosomiasis). 2023 Available from: https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis). Accessed 21 April 2023.
Noya BA, Díaz-Bello Z, Ruiz-Guevara R, Noya O. Chagas disease expands its epidemiological frontiers from rural to urban areas. Front Trop Dis. 2022;3:799009. https://doi.org/10.3389/fitd.2022.799009
Saraiva RM, Mediano MFF, Mendes FS, Silva GMS, Veloso HH, Sangenis LHC, et al. Chagas heart disease: an overview of diagnosis, manifestations, treatment, and care. World J Cardiol. 2021;13(12):654-675. https://doi.org/10.4330/wjc.v13.i12.654
Bocchi EA, Bestetti RB, Scanavacca MI, Cunha Neto E, Issa VS. Chronic Chagas heart disease management: from etiology to cardiomyopathy treatment. J Am Coll Cardiol. 2017;70(12):1510-1524. https://doi.org/10.1016/j.jacc.2017.08.004
Del Buono MG, Arena R, Borlaug BA, Carbone S, Canada JM, Kirkman DL, et al. Exercise intolerance in patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(17):2209-2225. https://doi.org/10.1016/j.jacc.2019.01.072
Mady C, Ianni BM, Arteaga E, Salemi VM, de Carvalho FC. Maximal functional capacity in patients with Chagas' cardiomyopathy without congestive heart failure. J Card Fail. 2000;6(3):220-224. https://doi.org/10.1054/jcaf.2000.8828
Vieira FC, de Melo MP, Brandão DC, Silva OB. Respiratory muscle strength, the six-minute walk test and quality of life in Chagas cardiomyopathy. Physiother Res Int. 2014;19(1):8-15. https://doi.org/10.1002/pri.1550
Costa HS, Lima MMO, Nunes MCP, Sousa GR, de Almeida FR, Figueiredo PHS, et al. Inspiratory muscle weakness in patients with Chagas heart disease: echocardiographic and functional predictors. IJC Metabolic & Endocrine. 2017;14:21-25. https://doi.org/10.1016/j.ijcme.2016.11.007
Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kübler W, et al. Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation. 2001;103(17):2153-2158. https://doi.org/10.1161/01.cir.103.17.2153
Mediano MF, Mendes FSNS, Pinto VL, Silva GMS, Silva PS, Carneiro FM, et al. Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study. Rev Soc Bras Med Trop. 2016;49(3):319-328. https://doi.org/10.1590/0037-8682-0083-2016
Baião EA, Costa Rocha MO, Lima MM, Parreira VF, Ribeiro AL, Britto RR, et al. Respiratory function and functional capacity in Chagas cardiomyopathy. Int J Cardiol. 2013;168(5):5059-5061. https://doi.org/10.1016/j.ijcard.2013.07.206
Mendes FSNS, Mediano MFF, Castro ESFC, Silva PS, Carneiro FM, Holanda MT, et al. Effect of physical exercise training in patients with Chagas heart disease (from the PEACH STUDY). Am J Cardiol. 2020;125(9):1413-1420. https://doi.org/10.1016/j.amjcard.2020.01.035
Frota AX, Mendes F, Vieira MC, Saraiva RM, Veloso HH, Silva PS, et al. Acute and subacute hemodynamic responses and perception of effort in subjects with chronic Chagas cardiomyopathy submitted to different protocols of inspiratory muscle training: a cross-over trial. Disabil Rehabil. 2022;44(8):1305-1312. https://doi.org/10.1080/09638288.2020.1800837
Mendes MFA, Lopes WS, Nogueira GA, Wilson A, Araújo SM, Gomes ML. Aerobic Physical exercise in women with Chagas disease. Fisioter Mov. 2011;24(4):591-601. https://doi.org/10.1590/S0103-51502011000400002
Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int J Cardiol. 2005;102(2):239-247. https://doi.org/10.1016/j.ijcard.2004.05.025
BRASIL. Resolução n° 466, de 12 de dezembro de 2012. [Provides for guidelines and regulatory standards for research involving human beings]. Brasília, DF: Diário Oficial [da] República Federativa do Brasil; 2013.
Dias JC, Ramos AN Jr, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. 2nd Brazilian Consensus on Chagas Disease. Rev Soc Bras Med Trop. 2017;50(1):149. https://doi.org/10.1590/0037-8682-0505-2016
Matsudo S, Araújo T, Matsudo V, Andrade D, Andrade E, Oliveira LC. International Physical Activity Questionnaire (IPAQ): validity and reproducibility study in Brazil. Rev Bras Ativ Física e Saúde. 2001;6(2):5. https://doi.org/10.12820/rbafs.v.6n2p5-18
Patterson E. Guidelines for the data processing and analysis of the International Physical Activity Questionnaire (IPAQ)- Short and Long forms: IPAQ Research Commitee. 2005 [cited 2022 May 13]. First edition: Available from: https://sites.google.com/site/theipaq/scoring-protocol
Neder JA, Andreoni S, Lerario MC, Nery LE. Reference values for lung function tests. II. Maximal respiratory pressures and voluntary ventilation. Braz J Med Biol Res. 1999;32(6):719-727. https://doi.org/10.1590/s0100-879x1999000600007
Laveneziana P, Albuquerque A, Aliverti A, Babb T, Barreiro E, Dres M, et al. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J. 2019;53(6):1801-1814. https://doi.org/10.1183/13993003.01214-2018
Dall'Ago P, Chiappa GR, Guths H, Stein R, Ribeiro JP. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol. 2006;47(4):757-763. https://doi.org/10.1016/j.jacc.2005.09.052
Silva FMF, Cipriano G, Lima A, Andrade JML, Nakano EY, Chiappa GR, et al. Maximal dynamic inspiratory pressure evaluation in heart failure: A comprehensive reliability and agreement study. Phys Ther. 2020;100(12):2246-2253. https://doi.org/10.1093/ptj/pzaa165
Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377-381.
Hill K, Jenkins SC, Philippe DL, Shepherd KL, Hillman DR, Eastwood PR. Comparison of incremental and constant load tests of inspiratory muscle endurance in COPD. Eur Respir J. 2007;30(3):479-486. https://doi.org/10.1183/09031936.00095406
Troosters T, Gosselink R, Decramer M. Respiratory muscle assessment. Lung function testing. European Respiratory Society monographs. Volume 10, Monograph 31. Sheffield, UK: European Respiratory Society; 2005. p. 217. https://doi.org/10.1183/1025448x.00031004
Fiz JA, Romero P, Gomez R, Hernandez MC, Ruiz J, Izquierdo J, et al. Indices of respiratory muscle endurance in healthy subjects. Respiration. 1998;65(1):21-27. https://doi.org/10.1159/000029223
Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg Am. 1984;9(2):222-226. https://doi.org/10.1016/s0363-5023(84)80146-x
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Buyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169
Hammer GP, du Prel JB, Blettner M. Avoiding bias in observational studies: part 8 in a series of articles on evaluation of scientific publications. Dtsch Arztebl Int. 2009;106(41):664-668. https://doi.org/10.3238/arztebl.2009.0664
American Thoracic Society/European Respiratory Society. ATS/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518-624. https://doi.org/10.1164/rccm.166.4.518
Nakagawa NK, Diz MA, Kawauchi TS, de Andrade GN, Umeda IIK, Murakami FM, et al. Risk factors for inspiratory muscle weakness in chronic heart failure. Respir Care. 2020;65(4):507-516. https://doi.org/10.4187/respcare.06766
Cahalin LP, Arena R, Guazzi M, Myers J, Cipriano G, Chiappa G, et al. Inspiratory muscle training in heart disease and heart failure: a review of the literature with a focus on method of training and outcomes. Expert Rev Cardiovasc Ther. 2013;11(2):161-177. https://doi.org/10.1586/erc.12.191
Langer D, Charususin N, Jácome C, Hoffman M, McConnell A, Decramer M, et al. Efficacy of a novel method for inspiratory muscle training in people with chronic obstructive pulmonary disease. Phys Ther. 2015;95(9):1264-1273. https://doi.org/10.2522/ptj.20140245
Janssens L, Brumagne S, McConnell AK, Raymaekers J, Goossens N, Gauyan-Ramirez G, et al. The assessment of inspiratory muscle fatigue in healthy individuals: a systematic review. Respir Med. 2013;107(3):331-346. https://doi.org/10.1016/j.rmed.2012.11.019
Costa HS, Lima MMO, Costa F, Chaves AT, Nunes MCP, Figueiredo PMS, et al. Reduced functional capacity in patients with Chagas disease: a systematic review with meta-analysis. Rev Soc Bras Med Trop. 2018;51(4):421-426. https://doi.org/10.1590/0037-8682-0158-2018
Parahiba SM, Spillere SR, Zuchinali P, Padilha GR, Duarte MB, da Silveira IV, et al. Handgrip strength in patients with acute decompensated heart failure: accuracy as a predictor of malnutrition and prognostic value. Nutrition. 2021;91-92:111352. https://doi.org/10.1016/j.nut.2021.111352
Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273. https://doi.org/10.1016/S0140-6736(14)62000-6
Fonseca G, Garfias MT, Ebner N, Santos MR, Souza FR, Mady C, et al. Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies. ESC Heart Fail. 2020;7(5):3086-3094. https://doi.org/10.1002/ehf2.12936
Ozcan EB, Saglam M, Vardar-Yagli N, Calik-Kutukcu E, Inal-Ince D, Altinsoy M, et al. Impaired balance and gait characteristics in patients with chronic heart failure. Heart Lung Circ. 2022;31(6):832-840. https://doi.org/10.1016/j.hlc.2021.10.015
Vizzoni AG, Varela MC, Sangenis LHC, Hasslocher-Moreno AM, Brasil PEAA, Saraiva RM. Ageing with Chagas disease: an overview of an urban Brazilian cohort in Rio de Janeiro. Parasit Vectors. 2018;11(1):354. https://doi.org/10.1186/s13071-018-2929-y
Bonney KM, Luthringer DJ, Kim SA, Garg NJ, Engman DM. Pathology and pathogenesis of Chagas heart disease. Annu Rev Pathol. 2019;14:421-447. https://doi.org/10.1146/annurev-pathol-020117-043711
Sharma G, Goodwin J. Effect of aging on respiratory system physiology and immunology. Clin Interv Aging. 2006;1(3):253-260. https://doi.org/10.2147/ciia.2006.1.3.253
Marrelli MT, Fiedler M, Biguetti C, Brotto M. Detrimental effects of malaria, toxoplasmosis, leishmaniosis and Chagas disease on cardiac and skeletal muscles. Med Res Arch. 2020;8(9):1-17. https://doi.org/10.18103/mra.v8i9.2218
Montes de Oca M, Torres SH, Loyo JG, Vazquez F, Hernández N, Anchustegui B, et al. Exercise performance and skeletal muscles in patients with advanced Chagas disease. Chest. 2004;125(4):1306-1314. https://doi.org/10.1378/chest.125.4.1306
Smith JR, Taylor BJ. Inspiratory muscle weakness in cardiovascular diseases: Implications for cardiac rehabilitation. Prog Cardiovasc Dis. 2022;70:49-57. https://doi.org/10.1016/j.pcad.2021.10.002
Hamazaki N, Kamiya K, Matsuzawa R, Nozaki K, Ichikawa T, Tanaka S, et al. Prevalence and prognosis of respiratory muscle weakness in heart failure patients with preserved ejection fraction. Respir Med. 2020;161:105834. https://doi.org/10.1016/j.rmed.2019.105834
Laoutaris I, Dritsas A, Brown MD, Manginas A, Alivizatos PA, Cokkinos DV. Inspiratory muscle training using an incremental endurance test alleviates dyspnea and improves functional status in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2004;11(6):489-496. https://doi.org/10.1097/01.hjr.0000152242.51327.63
Hossein Pour AH, Gholami M, Saki M, Birjandi M. The effect of inspiratory muscle training on fatigue and dyspnea in patients with heart failure: A randomized, controlled trial. Jpn J Nurs Sci. 2020;17(2):e12290. https://doi.org/10.1111/jjns.12290
Stein R, Chiappa GR, Güths H, Dall'Ago P, Ribeiro JP. Inspiratory muscle training improves oxygen uptake efficiency slope in patients with chronic heart failure. J Cardiopulm Rehabil Prev. 2009;29(6):392-395. https://doi.org/10.1097/HCR.0b013e3181b4cc41
Bosnak-Guclu M, Arikan H, Savci S, Inal-Ince D, Tulumen E, Aytemir K, et al. Effects of inspiratory muscle training in patients with heart failure. Respir Med. 2011;105(11):1671-1681. https://doi.org/10.1016/j.rmed.2011.05.001